Dex Pharma Reta Max 50mg/3mL Pen
The 50mg/3ml Retatrutide (GLP-3RT) pen is a next-generation metabolic optimizer that targets three different receptors: GLP-1, GIP, and Glucagon. This "triple agonist" approach makes it exceptionally powerful for weight management and metabolic health.
Retatrutide is often called a "3-Way Agonist" because it targets three metabolic pathways simultaneously, making it more potent than Semaglutide or Tirzepatide. By activating GLP-1, GIP, and Glucagon receptors, it addresses weight loss through appetite suppression and increased energy expenditure.
✓ 50mg total Retatrutide
✓ Up to 25 weeks at 2mg/week
✓ Equivalent cost from approximately R118/week at introductory dosing
✓ Triple-agonist technology (GLP-1 + GIP + Glucagon)
✓ Better mg-per-rand value than many competing pre-filled pens
Detailed Mechanism
GLP-1 & GIP: These work together to slow digestion, suppress appetite, and improve how your body handles insulin.
Glucagon Power: This third receptor is the "secret sauce"—it increases your resting metabolic rate and targets fat burning in the liver.
Triple Synergy: Combining these three allows for significant weight loss with potentially better metabolic protection than single or dual-agonist peptides.
Key Benefits
Maximized Fat Loss: Significant reduction in visceral and subcutaneous fat via enhanced metabolic rate.
Blood Sugar Regulation: Drastically improves insulin sensitivity and glucose control.
Appetite Suppression: Delays gastric emptying and signals fullness to the brain to reduce caloric intake.
Liver Health: Specifically researched for its ability to reduce liver fat more effectively than previous generations of GLP-1s.
Dosage Guide (50mg/3ml Pen)
This pen is highly concentrated. Following the official protocol:
Step 1 (Starting): 1–2 mg once weekly for Weeks 1–4.
Step 2 (Escalation): 2–3 mg weekly only if Step 1 was comfortable.
Step 3 (Therapeutic): 3–4 mg weekly. Most users find their long-term maintenance dose in this range.
Step 4 (Advanced): 4–6 mg weekly. Advance only if you have no side effects and your results have stalled.
Tips for Success
Titrate Slowly: Don't rush to increase the dose; the "right" dose is the lowest one that still provides results.
Hydration: Retatrutide can be dehydrating and may cause mild nausea; drink plenty of water and electrolytes.
Liver Support: It is particularly effective for those looking to improve liver markers alongside fat loss.
1. What makes Retatrutide different from Ozempic or Mounjaro? Retatrutide is a "triple agonist." While Ozempic hits one receptor and Mounjaro hits two, Retatrutide targets three (GLP-1, GIP, and Glucagon), leading to potentially higher metabolic rates and fat loss.
2. How does the Glucagon receptor help with weight loss? The Glucagon component increases energy expenditure and targets fat specifically in the liver, effectively "revving" your metabolic engine rather than just suppressed appetite.
3. What is the starting dose? Research protocols recommend starting at 1-2mg once per week for at least four weeks to allow the body to adjust.
4. How do I calculate the dose with a 50mg/3ml pen? With 50mg in 3ml, the concentration is approx 1.67mg per 0.1ml (10 units). Always double-check your pen's specific click-chart for exact milligram-to-click ratios.
5. How often do I take it? Retatrutide is administered once weekly, on the same day each week.
6. What are the most common side effects? Nausea, mild diarrhea, and fatigue are the most common. Because of the Glucagon component, some users also report a slightly elevated resting heart rate.
7. Do I have to titrate (increase) the dose every month? No. You should stay at the lowest effective dose as long as you are seeing results. Only move up if your progress stalls and side effects are non-existent.
8. Can I switch from Tirzepatide to Retatrutide? Yes, though most researchers suggest a "washout" period or starting at a lower Retatrutide dose to gauge the body's response to the third receptor.
9. How long does a 50mg pen last? Depending on your dose, it can last a long time. At a 2mg weekly dose, a 50mg pen technically contains 25 weeks of medication; however, shelf life after first use is generally 60 days.
10. Does it need to be refrigerated? Yes. To maintain the structural integrity of the triple-agonist peptide, the pen must be stored in the refrigerator.
11. Will it cause muscle loss? Any rapid weight loss can include muscle. It is critical to prioritize high protein intake (1.6g/kg) and resistance training while using this peptide.
12. When is the best time to inject? Most users prefer evening injections to "sleep through" any immediate nausea, though the specific time of day does not affect fat loss results.
13. Does it help with fatty liver? Yes, clinical data suggests Retatrutide is exceptionally effective at clearing liver fat due to its Glucagon receptor activity.
14. What should I do if I feel severe nausea? Hold your current dose (do not escalate) and focus on smaller, lower-fat meals. Ensure you are well-hydrated with electrolytes.
15. Can I drink alcohol on Retatrutide? It is generally discouraged, especially during the titration phase, as alcohol can worsen GI side effects and blood sugar fluctuations.
Quick Research Summary
Current research suggests that Retatrutide may offer strong potential in weight-management and metabolic-health research because of its triple-action activity on GIP, GLP-1, and glucagon receptors. Published Phase 2 studies have shown substantial body-weight reduction and major liver-fat reductions, while recent Phase 3 topline data from Lilly has reported strong A1C and weight-loss outcomes. However, retatrutide remains investigational, and full long-term safety, regulatory review, and approval decisions are still ongoing.
Important: Retatrutide is currently being researched and is not yet registered as an approved treatment. This information is provided for educational and research-reference purposes only and should not be taken as medical advice. Customers should consult a qualified healthcare professional before making any health-related decisions.
